| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 4 |
| Forrest at al. (procyclic) | no | yes: 4 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | yes | yes: 15 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000166 | nucleotide binding | 3 | 1 |
| GO:0003824 | catalytic activity | 1 | 7 |
| GO:0005488 | binding | 1 | 2 |
| GO:0015035 | protein-disulfide reductase activity | 3 | 5 |
| GO:0015036 | disulfide oxidoreductase activity | 4 | 5 |
| GO:0015038 | glutathione disulfide oxidoreductase activity | 5 | 2 |
| GO:0016209 | antioxidant activity | 1 | 2 |
| GO:0016491 | oxidoreductase activity | 2 | 5 |
| GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors | 3 | 5 |
| GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor | 4 | 5 |
| GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor | 4 | 2 |
| GO:0019153 | protein-disulfide reductase (glutathione) activity | 4 | 5 |
| GO:0036094 | small molecule binding | 2 | 1 |
| GO:0043167 | ion binding | 2 | 1 |
| GO:0043168 | anion binding | 3 | 1 |
| GO:0045174 | glutathione dehydrogenase (ascorbate) activity | 2 | 2 |
| GO:0050661 | NADP binding | 4 | 1 |
| GO:0070402 | NADPH binding | 4 | 1 |
| GO:0097159 | organic cyclic compound binding | 2 | 1 |
| GO:0140096 | catalytic activity, acting on a protein | 2 | 5 |
| GO:1901265 | nucleoside phosphate binding | 3 | 1 |
| GO:1901363 | heterocyclic compound binding | 2 | 1 |
| GO:0005515 | protein binding | 2 | 1 |
| GO:0042802 | identical protein binding | 3 | 1 |
| GO:0016740 | transferase activity | 2 | 3 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.435 |
| CLV_NRD_NRD_1 | 404 | 406 | PF00675 | 0.512 |
| CLV_NRD_NRD_1 | 84 | 86 | PF00675 | 0.349 |
| CLV_PCSK_FUR_1 | 402 | 406 | PF00082 | 0.512 |
| CLV_PCSK_KEX2_1 | 336 | 338 | PF00082 | 0.356 |
| CLV_PCSK_KEX2_1 | 404 | 406 | PF00082 | 0.542 |
| CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.372 |
| CLV_PCSK_PC1ET2_1 | 336 | 338 | PF00082 | 0.356 |
| CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.372 |
| CLV_PCSK_PC7_1 | 400 | 406 | PF00082 | 0.500 |
| CLV_PCSK_SKI1_1 | 129 | 133 | PF00082 | 0.393 |
| CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.493 |
| CLV_PCSK_SKI1_1 | 386 | 390 | PF00082 | 0.440 |
| DEG_SCF_FBW7_2 | 242 | 248 | PF00400 | 0.405 |
| DOC_CKS1_1 | 242 | 247 | PF01111 | 0.401 |
| DOC_CKS1_1 | 380 | 385 | PF01111 | 0.344 |
| DOC_MAPK_DCC_7 | 11 | 19 | PF00069 | 0.372 |
| DOC_MAPK_gen_1 | 212 | 218 | PF00069 | 0.386 |
| DOC_MAPK_MEF2A_6 | 11 | 19 | PF00069 | 0.372 |
| DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.544 |
| DOC_WW_Pin1_4 | 241 | 246 | PF00397 | 0.407 |
| DOC_WW_Pin1_4 | 379 | 384 | PF00397 | 0.344 |
| LIG_14-3-3_CanoR_1 | 157 | 161 | PF00244 | 0.482 |
| LIG_14-3-3_CanoR_1 | 262 | 271 | PF00244 | 0.304 |
| LIG_14-3-3_CanoR_1 | 295 | 300 | PF00244 | 0.290 |
| LIG_APCC_ABBA_1 | 198 | 203 | PF00400 | 0.460 |
| LIG_BRCT_BRCA1_1 | 194 | 198 | PF00533 | 0.356 |
| LIG_BRCT_BRCA1_1 | 297 | 301 | PF00533 | 0.272 |
| LIG_EH1_1 | 290 | 298 | PF00400 | 0.405 |
| LIG_eIF4E_1 | 291 | 297 | PF01652 | 0.405 |
| LIG_FHA_1 | 14 | 20 | PF00498 | 0.434 |
| LIG_FHA_1 | 266 | 272 | PF00498 | 0.536 |
| LIG_FHA_2 | 113 | 119 | PF00498 | 0.470 |
| LIG_FHA_2 | 389 | 395 | PF00498 | 0.584 |
| LIG_LIR_Gen_1 | 360 | 371 | PF02991 | 0.380 |
| LIG_LIR_Nem_3 | 172 | 177 | PF02991 | 0.560 |
| LIG_LIR_Nem_3 | 195 | 201 | PF02991 | 0.356 |
| LIG_LIR_Nem_3 | 228 | 233 | PF02991 | 0.397 |
| LIG_LIR_Nem_3 | 360 | 366 | PF02991 | 0.363 |
| LIG_MYND_3 | 14 | 18 | PF01753 | 0.405 |
| LIG_PCNA_TLS_4 | 55 | 62 | PF02747 | 0.405 |
| LIG_PTB_Apo_2 | 285 | 292 | PF02174 | 0.405 |
| LIG_PTB_Phospho_1 | 285 | 291 | PF10480 | 0.405 |
| LIG_REV1ctd_RIR_1 | 330 | 341 | PF16727 | 0.405 |
| LIG_SH2_CRK | 230 | 234 | PF00017 | 0.356 |
| LIG_SH2_CRK | 5 | 9 | PF00017 | 0.269 |
| LIG_SH2_GRB2like | 194 | 197 | PF00017 | 0.407 |
| LIG_SH2_GRB2like | 232 | 235 | PF00017 | 0.356 |
| LIG_SH2_PTP2 | 232 | 235 | PF00017 | 0.356 |
| LIG_SH2_SRC | 232 | 235 | PF00017 | 0.356 |
| LIG_SH2_SRC | 94 | 97 | PF00017 | 0.349 |
| LIG_SH2_STAP1 | 194 | 198 | PF00017 | 0.405 |
| LIG_SH2_STAP1 | 363 | 367 | PF00017 | 0.436 |
| LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.428 |
| LIG_SH2_STAT5 | 191 | 194 | PF00017 | 0.308 |
| LIG_SH2_STAT5 | 232 | 235 | PF00017 | 0.356 |
| LIG_SH2_STAT5 | 259 | 262 | PF00017 | 0.364 |
| LIG_SH2_STAT5 | 291 | 294 | PF00017 | 0.414 |
| LIG_SH2_STAT5 | 355 | 358 | PF00017 | 0.351 |
| LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.329 |
| LIG_SH2_STAT5 | 94 | 97 | PF00017 | 0.355 |
| LIG_SH3_3 | 216 | 222 | PF00018 | 0.479 |
| LIG_SH3_3 | 266 | 272 | PF00018 | 0.351 |
| LIG_SH3_3 | 364 | 370 | PF00018 | 0.223 |
| LIG_SUMO_SIM_anti_2 | 342 | 347 | PF11976 | 0.383 |
| LIG_TRAF2_1 | 391 | 394 | PF00917 | 0.558 |
| LIG_UBA3_1 | 345 | 353 | PF00899 | 0.382 |
| MOD_CDK_SPxxK_3 | 379 | 386 | PF00069 | 0.344 |
| MOD_CK2_1 | 388 | 394 | PF00069 | 0.537 |
| MOD_Cter_Amidation | 334 | 337 | PF01082 | 0.356 |
| MOD_GlcNHglycan | 180 | 183 | PF01048 | 0.488 |
| MOD_GlcNHglycan | 245 | 248 | PF01048 | 0.525 |
| MOD_GlcNHglycan | 358 | 362 | PF01048 | 0.434 |
| MOD_GlcNHglycan | 38 | 42 | PF01048 | 0.560 |
| MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.519 |
| MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.456 |
| MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.511 |
| MOD_GSK3_1 | 156 | 163 | PF00069 | 0.364 |
| MOD_N-GLC_1 | 101 | 106 | PF02516 | 0.405 |
| MOD_NEK2_1 | 37 | 42 | PF00069 | 0.499 |
| MOD_NEK2_1 | 48 | 53 | PF00069 | 0.395 |
| MOD_PIKK_1 | 250 | 256 | PF00454 | 0.372 |
| MOD_PKA_2 | 10 | 16 | PF00069 | 0.361 |
| MOD_PKA_2 | 156 | 162 | PF00069 | 0.329 |
| MOD_PKA_2 | 235 | 241 | PF00069 | 0.316 |
| MOD_Plk_1 | 112 | 118 | PF00069 | 0.416 |
| MOD_Plk_4 | 265 | 271 | PF00069 | 0.358 |
| MOD_Plk_4 | 27 | 33 | PF00069 | 0.507 |
| MOD_Plk_4 | 295 | 301 | PF00069 | 0.484 |
| MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.542 |
| MOD_ProDKin_1 | 241 | 247 | PF00069 | 0.407 |
| MOD_ProDKin_1 | 379 | 385 | PF00069 | 0.344 |
| MOD_SUMO_for_1 | 307 | 310 | PF00179 | 0.407 |
| MOD_SUMO_rev_2 | 305 | 309 | PF00179 | 0.435 |
| TRG_DiLeu_BaEn_1 | 266 | 271 | PF01217 | 0.365 |
| TRG_DiLeu_BaEn_2 | 280 | 286 | PF01217 | 0.405 |
| TRG_DiLeu_BaLyEn_6 | 367 | 372 | PF01217 | 0.405 |
| TRG_ENDOCYTIC_2 | 138 | 141 | PF00928 | 0.368 |
| TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.477 |
| TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.407 |
| TRG_ENDOCYTIC_2 | 363 | 366 | PF00928 | 0.335 |
| TRG_ENDOCYTIC_2 | 5 | 8 | PF00928 | 0.270 |
| TRG_ER_diArg_1 | 204 | 207 | PF00400 | 0.375 |
| TRG_ER_diArg_1 | 402 | 405 | PF00400 | 0.552 |
| TRG_Pf-PMV_PEXEL_1 | 175 | 180 | PF00026 | 0.483 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0S4IX62 | Bodo saltans | 40% | 85% |
| A0A0S4KHM5 | Bodo saltans | 41% | 85% |
| A0A1X0P247 | Trypanosomatidae | 46% | 92% |
| A0A3S7X699 | Leishmania donovani | 91% | 91% |
| A0A422NGA2 | Trypanosoma rangeli | 51% | 92% |
| A4HJ18 | Leishmania braziliensis | 79% | 100% |
| A4I8P2 | Leishmania infantum | 91% | 91% |
| Q70GE8 | Leishmania major | 92% | 100% |
| V5DBY4 | Trypanosoma cruzi | 47% | 92% |